MCDVX | VIVIX | MCDVX / VIVIX | |
Total Expense Ratio | 1.70 | 0.04 | 4,250% |
Annual Report Gross Expense Ratio | 1.70 | 0.04 | 4,250% |
Fund Existence | 30 years | 27 years | - |
Gain YTD | 4.792 | 2.421 | 198% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.3B | 195B | 9% |
Annual Yield % from dividends | 1.43 | 2.27 | 63% |
Returns for 1 year | -2.14 | 7.66 | -28% |
Returns for 3 years | -8.94 | 17.34 | -52% |
Returns for 5 years | 33.83 | 101.66 | 33% |
Returns for 10 years | -17.55 | 106.83 | -16% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NHS | 7.61 | -0.05 | -0.72% |
Neuberger Berman High Yield Strategies Fund | |||
DBEU | 43.11 | -1.14 | -2.58% |
Xtrackers MSCI Europe Hedged Equity ETF | |||
SROI | 28.20 | -0.77 | -2.67% |
Calamos Antetokounmpo Global Sus Eqs ETF | |||
GLV | 5.37 | -0.15 | -2.72% |
Clough Global Dividend and Income Fund | |||
DFSV | 26.23 | -2.38 | -8.32% |
Dimensional US Small Cap Value ETF |